These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22966725)

  • 41. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [An alternative therapy: the insulin pump].
    Martín E
    Rev Enferm; 2000 Apr; 23(4):308-12. PubMed ID: 10909359
    [No Abstract]   [Full Text] [Related]  

  • 43. [Development of the implantable artificial endocrine pancreas].
    Shichiri M; Nishida K; Sakakida M
    Nihon Rinsho; 1997 Nov; 55 Suppl():288-92. PubMed ID: 9434482
    [No Abstract]   [Full Text] [Related]  

  • 44. [Optimizing insulin therapy in children and adolescents with diabetes mellitus].
    Luo XP; Wu W
    Zhonghua Er Ke Za Zhi; 2010 Jun; 48(6):409-12. PubMed ID: 21055260
    [No Abstract]   [Full Text] [Related]  

  • 45. Insulin-pump therapy for type 1 diabetes mellitus.
    Pickup JC
    N Engl J Med; 2012 Apr; 366(17):1616-24. PubMed ID: 22533577
    [No Abstract]   [Full Text] [Related]  

  • 46. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of insulin pumps improves the metabolic control in children and adolescents with type 1 diabetes.
    Toni S; Reali MF; Fasulo A; Festini P; Medici A; Martinucci ME
    Arch Dis Child; 2004 Aug; 89(8):796-7. PubMed ID: 15269092
    [No Abstract]   [Full Text] [Related]  

  • 48. The future of basal insulin supplementation.
    Simon AC; DeVries JH
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S103-8. PubMed ID: 21568722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous use of two external subcutaneous pumps delivering insulin and SYMLIN: use of a double-pump system.
    Schorr AB; Ofan R
    J Diabetes Sci Technol; 2012 Nov; 6(6):1507-8. PubMed ID: 23294799
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of type 1 diabetes in children and adolescents using modern insulin pumps.
    Kordonouri O; Hartmann R; Danne T
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S118-24. PubMed ID: 21864743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Refining the closed loop in the data age: research-to-practice transitions in diabetes technology.
    Forlenza GP; Sankaranarayanan S; Maahs DM
    Diabetes Technol Ther; 2015 May; 17(5):304-6. PubMed ID: 25844981
    [No Abstract]   [Full Text] [Related]  

  • 52. Comment on "Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long acting versus short-acting insulins?".
    Pfützner A
    J Diabetes Sci Technol; 2011 Nov; 5(6):1627-8. PubMed ID: 22226291
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of U-500 regular insulin via continuous subcutaneous insulin infusion: clinical practice experience.
    Reutrakul S; Brown RL; Koh CK; Hor TK; Baldwin D
    J Diabetes Sci Technol; 2011 Jul; 5(4):1025-6. PubMed ID: 21880247
    [No Abstract]   [Full Text] [Related]  

  • 54. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management.
    Grunberger G; Bailey TS; Cohen AJ; Flood TM; Handelsman Y; Hellman R; Jovanovič L; Moghissi ES; Orzeck EA;
    Endocr Pract; 2010; 16(5):746-62. PubMed ID: 21356638
    [No Abstract]   [Full Text] [Related]  

  • 55. Ensuring valid measurements for a disabled population: an insulin pen pilot study.
    Williams AS; Schnarrenberger P
    J Diabetes Sci Technol; 2010 Jan; 4(1):230. PubMed ID: 20167190
    [No Abstract]   [Full Text] [Related]  

  • 56. Future directions for insulin therapy and diabetes treatment.
    Heinemann L
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2():69-79. PubMed ID: 18407034
    [No Abstract]   [Full Text] [Related]  

  • 57. Antihyperglycemic therapy for patients with renal failure.
    Mikhail N; Cope D
    JAMA; 2003 Aug; 290(8):1026-7; author reply 1027. PubMed ID: 12941669
    [No Abstract]   [Full Text] [Related]  

  • 58. Design of Hack-Resistant Diabetes Devices and Disclosure of Their Cyber Safety.
    Sackner-Bernstein J
    J Diabetes Sci Technol; 2017 Mar; 11(2):198-202. PubMed ID: 27837161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prolonged treatment of diabetes mellitus with the portable insulin pump. Value of a 100 IU/ml concentrated insulin preparation].
    Pinget M; Selam JL; Dorner M; Mirouze J
    Presse Med; 1983 Sep; 12(32):2000. PubMed ID: 6225109
    [No Abstract]   [Full Text] [Related]  

  • 60. [Long-term results of therapy of patients with diabetes mellitus and secondary resistance to sulfanilamides].
    Pan'kiv VI
    Probl Endokrinol (Mosk); 1992; 38(1):12-4. PubMed ID: 1308584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.